AXSM
Price
$90.70
Change
+$0.96 (+1.07%)
Updated
Dec 20, 04:59 PM (EDT)
71 days until earnings call
JBPHF
Price
$0.29
Change
-$0.07 (-19.44%)
Updated
Feb 20 closing price
Ad is loading...

AXSM vs JBPHF

Header iconAXSM vs JBPHF Comparison
Open Charts AXSM vs JBPHFBanner chart's image
Axsome Therapeutics
Price$90.70
Change+$0.96 (+1.07%)
Volume$10.28K
CapitalizationN/A
Jacobio Pharmaceuticals Group
Price$0.29
Change-$0.07 (-19.44%)
Volume$5K
CapitalizationN/A
AXSM vs JBPHF Comparison Chart
Loading...
AXSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXSM vs. JBPHF commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXSM is a Hold and JBPHF is a Buy.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (AXSM: $90.73 vs. JBPHF: $0.29)
Brand notoriety: AXSM and JBPHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXSM: 186% vs. JBPHF: 100%
Market capitalization -- AXSM: $4.4B vs. JBPHF: $130.96M
AXSM [@Biotechnology] is valued at $4.4B. JBPHF’s [@Biotechnology] market capitalization is $130.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXSM’s FA Score shows that 0 FA rating(s) are green whileJBPHF’s FA Score has 1 green FA rating(s).

  • AXSM’s FA Score: 0 green, 5 red.
  • JBPHF’s FA Score: 1 green, 4 red.
According to our system of comparison, AXSM is a better buy in the long-term than JBPHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXSM’s TA Score shows that 5 TA indicator(s) are bullish.

  • AXSM’s TA Score: 5 bullish, 4 bearish.

Price Growth

AXSM (@Biotechnology) experienced а +0.70% price change this week, while JBPHF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

AXSM is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXSM($4.4B) has a higher market cap than JBPHF($131M). AXSM YTD gains are higher at: 13.997 vs. JBPHF (-19.089).
AXSMJBPHFAXSM / JBPHF
Capitalization4.4B131M3,358%
EBITDA-298.59MN/A-
Gain YTD13.997-19.089-73%
P/E RatioN/AN/A-
Revenue338MN/A-
Total Cash327MN/A-
Total Debt192MN/A-
FUNDAMENTALS RATINGS
AXSM: Fundamental Ratings
AXSM
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
48
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AXSMJBPHF
RSI
ODDS (%)
Bullish Trend 3 days ago
72%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
N/A
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
12%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
9%
Advances
ODDS (%)
Bullish Trend 20 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
75%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
N/A
View a ticker or compare two or three
Ad is loading...
AXSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FIGS5.750.16
+2.86%
FIGS
L83.191.53
+1.87%
Loews Corp
WKSP0.830.01
+1.03%
Worksport Ltd
HAYW15.440.10
+0.65%
Hayward Holdings
JYNT10.27-0.02
-0.19%
Joint Corp (The)

AXSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXSM has been loosely correlated with XENE. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AXSM jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXSM
1D Price
Change %
AXSM100%
+1.10%
XENE - AXSM
43%
Loosely correlated
-0.69%
ALT - AXSM
42%
Loosely correlated
+0.86%
CRNX - AXSM
42%
Loosely correlated
+1.63%
PLRX - AXSM
41%
Loosely correlated
-0.68%
MLTX - AXSM
40%
Loosely correlated
+0.56%
More

JBPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, JBPHF has been closely correlated with RAPT. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if JBPHF jumps, then RAPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JBPHF
1D Price
Change %
JBPHF100%
N/A
RAPT - JBPHF
79%
Closely correlated
+2.18%
AXSM - JBPHF
32%
Poorly correlated
+1.10%
PYPD - JBPHF
23%
Poorly correlated
-8.00%
FRTX - JBPHF
22%
Poorly correlated
-0.34%
LXRX - JBPHF
21%
Poorly correlated
-1.23%
More